ADD3 and cancer: Another in vitro study described an increase in ADD3 expression in temozolomide resistant glioblastoma cells and that its expression is colocalized with CD133 in glioma stem-like cells, suggestive of a positive correlation between ADD3 and cancer stem cell phenotype as well as chemoresistance [167].